These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 29079294)

  • 1. Direct pharmacological Akt activation rescues Alzheimer's disease like memory impairments and aberrant synaptic plasticity.
    Yi JH; Baek SJ; Heo S; Park HJ; Kwon H; Lee S; Jung J; Park SJ; Kim BC; Lee YC; Ryu JH; Kim DH
    Neuropharmacology; 2018 Jan; 128():282-292. PubMed ID: 29079294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Davunetide improves spatial learning and memory in Alzheimer's disease-associated rats.
    Zhang J; Wei SY; Yuan L; Kong LL; Zhang SX; Wang ZJ; Wu MN; Qi JS
    Physiol Behav; 2017 May; 174():67-73. PubMed ID: 28257938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.
    Kimura R; Devi L; Ohno M
    J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subchronic glucocorticoid receptor inhibition rescues early episodic memory and synaptic plasticity deficits in a mouse model of Alzheimer's disease.
    Lanté F; Chafai M; Raymond EF; Pereira AR; Mouska X; Kootar S; Barik J; Bethus I; Marie H
    Neuropsychopharmacology; 2015 Jun; 40(7):1772-81. PubMed ID: 25622751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cassia obtusifolia seed ameliorates amyloid β-induced synaptic dysfunction through anti-inflammatory and Akt/GSK-3β pathways.
    Yi JH; Park HJ; Lee S; Jung JW; Kim BC; Lee YC; Ryu JH; Kim DH
    J Ethnopharmacol; 2016 Feb; 178():50-7. PubMed ID: 26674159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bis(propyl)-cognitin Prevents β-amyloid-induced Memory Deficits as Well as Synaptic Formation and Plasticity Impairments via the Activation of PI3-K Pathway.
    Jiang L; Huang M; Xu S; Wang Y; An P; Feng C; Chen X; Wei X; Han Y; Wang Q
    Mol Neurobiol; 2016 Aug; 53(6):3832-3841. PubMed ID: 26160762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of chronic stimulation of serotonin receptor type 7 on recognition, passive avoidance memory, hippocampal long-term potentiation, and neuronal apoptosis in the amyloid β protein treated rat.
    Shahidi S; Asl SS; Komaki A; Hashemi-Firouzi N
    Psychopharmacology (Berl); 2018 May; 235(5):1513-1525. PubMed ID: 29637287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.
    Wu M; Shi H; He Y; Yuan L; Qu X; Zhang J; Wang Z; Cai H; Qi J
    J Alzheimers Dis; 2017; 59(3):1067-1078. PubMed ID: 28731445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin improves synaptic plasticity and memory deficits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease.
    Esmaeili Tazangi P; Moosavi SM; Shabani M; Haghani M
    Pharmacol Biochem Behav; 2015 Mar; 130():15-21. PubMed ID: 25553822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akt and calcium-permeable AMPA receptor are involved in the effect of pinoresinol on amyloid β-induced synaptic plasticity and memory deficits.
    Yu J; Cho E; Kwon H; Jeon J; Seong Sin J; Kwon Park J; Kim JS; Woong Choi J; Jin Park S; Jun M; Choon Lee Y; Hoon Ryu J; Lee J; Moon M; Lee S; Hyun Cho J; Hyun Kim D
    Biochem Pharmacol; 2021 Feb; 184():114366. PubMed ID: 33310049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
    Devi L; Ohno M
    Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of aberrant proteasome activity re-establishes plasticity and long-term memory in an animal model of Alzheimer's disease.
    Krishna-K K; Baby N; Raghuraman R; Navakkode S; Behnisch T; Sajikumar S
    FASEB J; 2020 Jul; 34(7):9466-9479. PubMed ID: 32459037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
    Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT
    J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats.
    Cai HY; Hölscher C; Yue XH; Zhang SX; Wang XH; Qiao F; Yang W; Qi JS
    Neuroscience; 2014 Sep; 277():6-13. PubMed ID: 24583037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.
    Caccamo A; Branca C; Talboom JS; Shaw DM; Turner D; Ma L; Messina A; Huang Z; Wu J; Oddo S
    J Neurosci; 2015 Oct; 35(41):14042-56. PubMed ID: 26468204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases.
    Zare D; Rajizadeh MA; Maneshian M; Jonaidi H; Sheibani V; Asadi-Shekaari M; Yousefi M; Esmaeilpour K
    Psychopharmacology (Berl); 2021 Jun; 238(6):1645-1656. PubMed ID: 33624157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TL-2 attenuates β-amyloid induced neuronal apoptosis through the AKT/GSK-3β/β-catenin pathway.
    Zhu X; Wang S; Yu L; Yang H; Tan R; Yin K; Jin J; Zhao H; Guan D; Xu Y
    Int J Neuropsychopharmacol; 2014 Sep; 17(9):1511-9. PubMed ID: 24641999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer's disease models through the Akt/GSK-3β/β-catenin signaling.
    Wang Y; Chen S; Xu Z; Chen S; Yao W; Gao X
    Neuropharmacology; 2018 Mar; 131():190-199. PubMed ID: 29223528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease.
    Gao L; Tian M; Zhao HY; Xu QQ; Huang YM; Si QC; Tian Q; Wu QM; Hu XM; Sun LB; McClintock SM; Zeng Y
    J Neurochem; 2016 Feb; 136(3):620-36. PubMed ID: 26577931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.